NCT01482065View on ClinicalTrials.gov

The Sleep, Liver Evaluation and Effective Pressure Study

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions
Non Alcoholic Fatty Liver DiseaseObstructive Sleep Apnea
Interventions
DEVICE

CPAP (ResMed S9 autoset CPAP)

A ResMed S9 autoset CPAP device will be utilized throughout the study. Throughout the study intervention period, subjects (for AHI\> 15) will be instructed to utilize their CPAP and adherence will be monitored using an automatic meter that is built into the CPAP device.

Trial Locations (1)

21224

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

ResMed Foundation

OTHER

lead

Johns Hopkins University

OTHER

NCT01482065 - The Sleep, Liver Evaluation and Effective Pressure Study | Biotech Hunter | Biotech Hunter